Clinical Trials › NCT06629428
RecruitingPhase 1
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
Sponsored by Georgia State University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 25
Target enrollment
1
U.S. states
Nov 2025
Start date
Dec 2026
Expected completion
Interventions / Treatments
Ublituximab
Conditions studied
Multiple Sclerosis (MS) - Relapsing-remitting
Where this trial is running (2 sites)
Georgia2 sites
Atlanta · Atlanta
Participating MS centers on MS Buddy (1)
ANI Multiple Sclerosis Center
Atlanta, GA
Atlanta, GA
MS centers in Georgia
Compare treatment centers near a trial site by center type, providers and trials.
View Georgia centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.